Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene
Phase 2 Completed
88 enrolled
Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma
Phase 2 Completed
49 enrolled 5 charts
A Study of Erlotinib Plus Radiotherapy (RT) for Patients With Advanced or Inoperable Non-Small-Cell Lung Cancer
Phase 2 Completed
17 enrolled 9 charts
A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer
Phase 2 Completed
83 enrolled 17 charts
A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial
Phase 2 Completed
13 enrolled
Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
Phase 2 Completed
647 enrolled 17 charts
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
43 enrolled 16 charts
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Phase 2 Completed
673 enrolled 22 charts
Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
123 enrolled 13 charts
BLISS
Phase 2 Completed
154 enrolled
Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer
Phase 2 Completed
123 enrolled 11 charts
Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy
Phase 2 Completed
45 enrolled 7 charts
BELIEF
Phase 2 Completed
109 enrolled 20 charts
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
Phase 2 Completed
46 enrolled 13 charts
NSCLC
Phase 2 Completed
32 enrolled 8 charts
Pemetrexed Plus Tarceva as Salvage Treatment in EGFR Overexpressed Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy
Phase 2 Completed
29 enrolled
Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)
Phase 2 Completed
166 enrolled 11 charts
Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer
Phase 2 Completed
62 enrolled 8 charts
BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
Phase 2 Completed
334 enrolled 14 charts
Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia
Phase 2 Completed
38 enrolled 14 charts
Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung Cancer
Phase 2 Completed
44 enrolled 16 charts
GEM
Phase 2 Completed
120 enrolled
Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment
Phase 2 Completed
201 enrolled 12 charts
Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Phase 2 Completed
20 enrolled 11 charts
LADIE
Phase 2 Completed
379 enrolled
TARLAL
Phase 2 Completed
15 enrolled 6 charts
Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations
Phase 2 Completed
88 enrolled 15 charts
NVALT10
Phase 2 Completed
195 enrolled
Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer
Phase 2 Completed
79 enrolled 13 charts
Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer
Phase 2 Completed
34 enrolled 9 charts
Erlotinib and SBRT in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Phase 2 Completed
24 enrolled 12 charts
Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer
Phase 2 Completed
1 enrolled
Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
Phase 2 Completed
17 enrolled
Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer
Phase 2 Completed
90 enrolled 11 charts
ChemoRT With Adjuvant Chemo in Pancreatic Cancer (TARCEVA)
Phase 2 Completed
48 enrolled 11 charts
Erlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase 2 Completed
50 enrolled
Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer Patients
Phase 2 Completed
82 enrolled
S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma
Phase 2 Completed
84 enrolled 15 charts
S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
Phase 2 Completed
89 enrolled 11 charts
S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase 2 Completed
59 enrolled 13 charts
BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Phase 2 Completed
37 enrolled 9 charts
Pemetrexed and Erlotinib for Metastatic Colorectal Cancer
Phase 2 Completed
50 enrolled
OSI-774 (Erlotinib, Tarceva) in Elderly Patients
Phase 2 Completed
30 enrolled
Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung
Phase 2 Completed
84 enrolled 12 charts
TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)
Phase 2 Completed
68 enrolled 11 charts
Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Phase 2 Completed
123 enrolled 10 charts
Chime
Phase 2 Completed
111 enrolled 20 charts
Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer
Phase 2 Completed
188 enrolled 16 charts
Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
Phase 2 Completed
37 enrolled 13 charts
Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV NSCLC
Phase 2 Completed
104 enrolled